About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Enrolling By InvitationNANCT06919133

The Effect of Digital Markers in the Self-management of Depressive Symptoms

The purpose of the MENTINA trial is to investigate the effect of using the smartphone-based MENTINA app for self-monitoring of depressive symptoms and rule-based feedback in individuals with current o...

Lead sponsor: Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital•3 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital

Collaborators

Hospital del Mar Research Institute (IMIM)
Research Centre of the German Foundation for Depression and Suicide Prevention
Monsenso
Monsenso A/S as sponsor

The intervention in the MENTINA trial consist of a smartphone app, which allows for daily monitoirng of symptoms such as mood, sleep, activity etc. Also, a library with content concerning depressive symptoms will be available. Rules for feedback based of self-reported measures will be developed. Based on the self-reported measures participants will be suggested to read items from the library or call emergency health care facilities.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Age 18 years or older
•Depressive symptoms, assessed by PHQ-9 \> 8, AND/OR
•Current or previous depressive episode(s) (ICD-10 F32, F33)
•Owns and uses a smartphone
•Signed informed consent to participate

Exclusion Criteria

•ICD-10 diagnosis of dementia, schizophrenia, mania, or bipolar disorder, as well as ongoing substance abuse
•Current psychotic depression
•Current suicide risk
•Acute somatic illness requiring treatment (intensive care)
•Insufficient language skills in Danish, German or Spanish and english (depending on site)

Related studies

Analgesic Efficacy of Multisite rTMS in Fibromyalgia Patients

NCT07642882 · Fibromyalgia, Depression - Major Depressive Disorder, and more

RECRUITINGPhase 2

Stratified Pharmacological Approaches for Regulating Circuit-Level Effects

NCT07022405 · Depression - Major Depressive Disorder

Narrative Therapy Among Young People With Moderate Level of Mental Distress in Hong Kong

NCT07231406 · Mental Distress

RECRUITINGPhase 3

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

NCT06793397 · Major Depressive Disorder (MDD), Depression in Adults, and more

RECRUITINGPhase 4

TDM-Guided Treatment With SSRIs in Hospitalized Adults and Children

NCT07478796 · Depression - Major Depressive Disorder, Depressive Episodes

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 14, 2026Terms

Trial snapshot

StatusENROLLING_BY_INVITATION

PhaseNA

Enrollment660

Start dateMay 2025

Last updatedJan 14, 2026

Condition

Depression - Major Depressive Disorder Mental Distress

Locations shown

Psychiatric Center Copenhagen

Frederiksberg

Frankfurt University Hospital

Frankfurt

Hospital del Mar

Barcelona

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 14, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions